That said, I'm also somewhat skeptical that there is even much room for growth left unless somebody finds a new, important, and token-hungry use case.
That said, I'm also somewhat skeptical that there is even much room for growth left unless somebody finds a new, important, and token-hungry use case.
If Anthropic manages to start producing new pharmaceuticals with their internal models or something that thesis could make sense but not if 90% of their revenue comes from enterprise API sales which would necessarily have to be accessible to the public. Which are then inevitably fast followed by Chinese models 3 months later.
[1] I don't, I think China is primarily limited by compute and will be at least for the next couple of years, probably longer.
They are also (like other models we know about) experimenting with the architecture. [2]
[1] https://arxiv.org/abs/2501.12948
[2] https://sebastianraschka.com/blog/2026/kimi-k3-architecture-...